• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺和秋水仙碱治疗白塞病的长期疗效。

Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.

作者信息

Kazokoglu H, Saatçi O, Cuhadaroglu H, Eldem B

机构信息

Department of Ophthalmology, Marmara Medical School, Istanbul, Turkey.

出版信息

Ann Ophthalmol. 1991 Apr;23(4):148-51.

PMID:2064258
Abstract

We assessed the long-term effects of cyclophosphamide and colchicine on visual prognosis and attack frequency in 64 patients with Behcet's disease who were studied in two separate groups between the years of 1976 and 1989. No statistically significant positive changes in visual acuity or attack frequency which might be attributed to the treatment could be shown when the period of treatment was compared with the period after treatment.

摘要

我们评估了环磷酰胺和秋水仙碱对64例白塞病患者视力预后和发作频率的长期影响,这些患者在1976年至1989年间被分为两个独立的组进行研究。当将治疗期与治疗后时期进行比较时,未发现可归因于治疗的视力或发作频率有统计学意义的积极变化。

相似文献

1
Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.环磷酰胺和秋水仙碱治疗白塞病的长期疗效。
Ann Ophthalmol. 1991 Apr;23(4):148-51.
2
Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.英夫利昔单抗单药治疗与英夫利昔单抗和秋水仙碱联合治疗 Behçet 病患者的效果比较。
Ocul Immunol Inflamm. 2012 Jun;20(3):193-7. doi: 10.3109/09273948.2012.665124. Epub 2012 Apr 9.
3
[Ocular prognosis in Behçet's disease].
J Fr Ophtalmol. 1992;15(5):343-7.
4
Cyclosporine in Behçet's disease resistant to conventional therapy.
Ann Ophthalmol. 1989 Mar;21(3):111-6, 118.
5
[Treatment of Behçet's syndrome with colchicine].[秋水仙碱治疗白塞病]
Riv Eur Sci Med Farmacol. 1989 Jun;11(3):257-61.
6
[Colchicine in Behcet's disease].[秋水仙碱治疗白塞病]
Harefuah. 1977 Dec 15;93(12):399-400.
7
Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.贝赫切特综合征男性患者发病时黏膜皮肤受累的预后:一项对照试验中纳入患者的长期结局。
Rheumatology (Oxford). 2010 Jan;49(1):173-7. doi: 10.1093/rheumatology/kep350.
8
[Immunosuppressive treatment of Behçet's syndrome. Long-term results].[白塞病的免疫抑制治疗。长期结果]
Ophtalmologie. 1989 Jan-Mar;3(1):40-2.
9
Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.叶酸降低高同型半胱氨酸血症对眼型白塞病有益吗?一项初步研究。
Tunis Med. 2007 Jun;85(6):450-3.
10
[Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].白塞病的免疫抑制治疗。长期随访评估(作者译)
J Fr Ophtalmol. 1981;4(6-7):455-64.

引用本文的文献

1
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies.优化贝赫切特葡萄膜炎的管理:个性化免疫抑制策略的综述。
Med Sci Monit. 2024 May 7;30:e943240. doi: 10.12659/MSM.943240.
2
Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.对于其他免疫调节治疗无效的严重眼部炎性疾病患者,采用静脉注射环磷酰胺治疗。
J Ophthalmic Inflamm Infect. 2024 Mar 11;14(1):12. doi: 10.1186/s12348-023-00372-z.
3
Systemic immunosuppressive therapies for uveitis in developing countries.
发展中国家葡萄膜炎的全身免疫抑制疗法。
Indian J Ophthalmol. 2020 Sep;68(9):1852-1862. doi: 10.4103/ijo.IJO_1548_20.
4
Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease.在接受英夫利昔单抗全身治疗的白塞病相关性难治性葡萄膜炎患者中进行白内障手术。
Ann Saudi Med. 2014 Jul-Aug;34(4):328-33. doi: 10.5144/0256-4947.2014.328.
5
Behçet syndrome: from pathogenesis to novel therapies.白塞病:从发病机制到新疗法
Clin Exp Med. 2016 Feb;16(1):1-12. doi: 10.1007/s10238-014-0328-z. Epub 2014 Dec 2.
6
Outcome measures used in clinical trials for Behçet syndrome: a systematic review.白塞病临床试验中使用的结局指标:一项系统评价。
J Rheumatol. 2014 Mar;41(3):599-612. doi: 10.3899/jrheum.131249. Epub 2014 Feb 1.
7
Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.白塞病的循证医学实践:确定2014年未满足需求的领域。
Orphanet J Rare Dis. 2014 Jan 30;9:16. doi: 10.1186/1750-1172-9-16.
8
Cyclophosphamide for ocular inflammatory diseases.环磷酰胺治疗眼部炎症性疾病。
Ophthalmology. 2010 Feb;117(2):356-65. doi: 10.1016/j.ophtha.2009.06.060. Epub 2009 Dec 6.
9
Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement.白塞病眼部受累视力预后不良的风险及预后因素
Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1147-52. doi: 10.1007/s00417-005-0005-8. Epub 2005 Jun 28.
10
Pharmacotherapy for Behcet's syndrome.白塞病的药物治疗
Cochrane Database Syst Rev. 2000;1998(2):CD001084. doi: 10.1002/14651858.CD001084.